Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Bcl-2 Family
    (4)
  • Ligands for Target Protein for PROTAC
    (2)
Filter
Search Result
Results for "

abt 263

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • PROTAC Products
    2
    TargetMol | PROTAC
  • Isotope Products
    1
    TargetMol | Isotope_Products
Navitoclax
ABT-263
T2101923564-51-6
Navitoclax (ABT-263) is a potent oral Bcl-2 inhibitor that binds to Bcl-xL, Bcl-2, and Bcl-w proteins (Ki<1 nM), demonstrating antitumor activity and inducing apoptosis.
  • $39
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Navitoclax-piperazine
ABT-263-piperazine
T121862143096-93-7
Navitoclax-piperazine (ABT-263-piperazine) is a B-cell lymphoma extra large (BCL-XL) inhibitor.
  • $67
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Desmorpholinyl Navitoclax-NH-Me
Desmorpholinyl Navitoclax-NH-Me, Desmorpholinyl ABT-263-NH-Me
T399102365172-82-1
Desmorpholinyl Navitoclax-NH-Me (Desmorpholinyl ABT-263-NH-Me) is a Bcl-xL inhibitor, which can be employed alongside a CRBN ligand to synthesize XZ739, a PROTAC BCL-XL degrader [1] [2].
  • $46
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Navitoclax-d8
TMID-12281217620-38-6
Navitoclax-d8 is the deuterated form of Navitoclax. Navitoclax (ABT-263) is a potent and orally bioavailable Bcl-2 inhibitor, capable of binding to various Bcl-2 family proteins including Bcl-xL, Bcl-2, and Bcl-w, with a Ki value of less than 1 nM.
  • Inquiry Price
Inquiry
Size
QTY